Abstract
Aromatic hydrocarbon (AH) effects are mediated by binding of the AH receptor and its heterodimeric partner aromatic hydrocarbon nuclear translocator to specific response elements on DNA (AHREs). CYP1A2 expression is induced by AHs, yet AHREs have been identified in CYP1A2 genes of only two species and their functional role assessed only in the human gene. There have been few analyses of CYP1A2 gene regulation in nonhepatic cells. To gain further insight into CYP1A2 regulation, we cloned the initial 1.2 kilobases (kb) of the guinea pig CYP1A2 gene 5′-flanking region and characterized CYP1A2 expression in guinea pig colon adenocarcinoma cells (GPC16). Two putative AHRE sites were identified (-830 and -575 bp). They are considerably more proximal than the functional AHRE found in the human CYP1A2 gene (-2.5 kb). GPC16 cells expressed CYP1A2 after treatment with AH, enabling characterization of the putative AHRE sites in a homologous cell line. Double-stranded oligonucleotide probes, corresponding to each putative AHRE, bound in an AH-induced and specific manner to nuclear proteins prepared from GPC16 cells. In transfection analyses, only the distal site mediated AH-induced reporter gene activity. Mutation of this site suppressed AH-induced activity, supporting the concept that it is involved in AH-mediated induction of CYP1A2. However, the low level of AH-induction by the wild type suggests that other factors modulate AH-response by the CYP1A2 gene.
Footnotes
-
↵1 Abbreviations used are: AH, aromatic hydrocarbon; AHR, AH receptor; ARNT, AH nuclear translocator; DRE, dioxin response element; XRE, xenobiotic response element; AHRE, AH response element; kb, kilobase; RT-PCR, reverse transcriptase-polymerase chain reaction; nt, nucleotide; 3MC, 3-methylcholanthrene; SEAP, secreted alkaline phosphatase; MEM, minimal essential medium; DMSO, dimethylsulfoxide; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; RLU, relative light units; EMSA, electrophoretic mobility shift assay; bp, base pair; NF, nuclear factor.
-
This work was supported by pilot project funds received from NIH ES00260 (V.H.B.), the Philip Morris External Research Program (V.H.B.), and NIH GM54477 (L.C.Q.). It was presented, in part, at the 11th International Conference on Cytochrome P450, Sendai, Japan, August 29-September 2, 1999, and the annual meeting of the American Society for Cell Biology, San Francisco, CA, December 9-13, 2000.
- Received September 25, 2003.
- Accepted February 23, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|